share_log

424B5: Prospectus

424B5: Prospectus

424B5:募資說明書
美股SEC公告 ·  08/19 18:08
牛牛AI助理已提取核心訊息
Cingulate has filed a prospectus supplement on August 19, 2024, to update its previous prospectus dated January 13, 2023. This new filing, made under Rule 424(b)(5) with Registration No. 333-269104, amends the amount of common stock Cingulate can offer and sell. The company is now eligible to sell shares with an aggregate offering price of up to $2,856,658 through H.C. Wainwright & Co., LLC, acting as the sales agent. This figure is in addition to the $8,468,402.99 worth of common stock already sold under the prior prospectus. The public float of Cingulate's common stock as of August 19, 2024, was valued at $28,709,843.98, based on the closing price of $17.69 per share on August 16, 2024. Over the past 12 months, the company has sold securities valued at $6,712,097.89. Cingulate's common stock is traded on the Nasdaq Capital Market under the ticker symbol 'CING'.
Cingulate has filed a prospectus supplement on August 19, 2024, to update its previous prospectus dated January 13, 2023. This new filing, made under Rule 424(b)(5) with Registration No. 333-269104, amends the amount of common stock Cingulate can offer and sell. The company is now eligible to sell shares with an aggregate offering price of up to $2,856,658 through H.C. Wainwright & Co., LLC, acting as the sales agent. This figure is in addition to the $8,468,402.99 worth of common stock already sold under the prior prospectus. The public float of Cingulate's common stock as of August 19, 2024, was valued at $28,709,843.98, based on the closing price of $17.69 per share on August 16, 2024. Over the past 12 months, the company has sold securities valued at $6,712,097.89. Cingulate's common stock is traded on the Nasdaq Capital Market under the ticker symbol 'CING'.
Cingulate於2024年8月19日提交了一份招股書補充說明,以更新其之前於2023年1月13日的招股書。根據333-269104號註冊,在424(b)(5)規則下進行此次申報修正了Cingulate可供出售的普通股數量。該公司現有資格向H.C. Wainwright & Co., LLC銷售股票,代理銷售人,並可出售總價值高達2,856,658美元的股票。此數據不包括之前招股書出售的總價值達8,468,402.99美元的普通股。截至2024年8月19日,Cingulate的公共流通股價值爲28,709,843.98美元,根據2024年8月16日每股17.69美元的收盤價計算。在過去的12個月裏,該公司已經出售了總價值達6,712,097.89美元的證券。Cingulate的普通股在納斯達克資本市場以股票代號「CING」進行交易。
Cingulate於2024年8月19日提交了一份招股書補充說明,以更新其之前於2023年1月13日的招股書。根據333-269104號註冊,在424(b)(5)規則下進行此次申報修正了Cingulate可供出售的普通股數量。該公司現有資格向H.C. Wainwright & Co., LLC銷售股票,代理銷售人,並可出售總價值高達2,856,658美元的股票。此數據不包括之前招股書出售的總價值達8,468,402.99美元的普通股。截至2024年8月19日,Cingulate的公共流通股價值爲28,709,843.98美元,根據2024年8月16日每股17.69美元的收盤價計算。在過去的12個月裏,該公司已經出售了總價值達6,712,097.89美元的證券。Cingulate的普通股在納斯達克資本市場以股票代號「CING」進行交易。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。